IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296 | +41.6% | 6,557 | +27.6% | 0.00% | – |
| Q2 2023 | $209 | -5.0% | 5,137 | -17.0% | 0.00% | – |
| Q1 2023 | $220 | +58.3% | 6,188 | +66.2% | 0.00% | – |
| Q4 2022 | $139 | -99.9% | 3,723 | -8.0% | 0.00% | – |
| Q3 2022 | $178,000 | -14.0% | 4,045 | -28.1% | 0.00% | – |
| Q2 2022 | $207,000 | +11.3% | 5,625 | +11.2% | 0.00% | – |
| Q1 2022 | $186,000 | +5.7% | 5,057 | -13.0% | 0.00% | – |
| Q4 2021 | $176,000 | +319.0% | 5,814 | +361.4% | 0.00% | – |
| Q3 2021 | $42,000 | -43.2% | 1,260 | -33.4% | 0.00% | – |
| Q2 2021 | $74,000 | +7300.0% | 1,891 | +5010.8% | 0.00% | – |
| Q1 2021 | $1,000 | -99.1% | 37 | -98.2% | 0.00% | – |
| Q4 2020 | $115,000 | +109.1% | 2,046 | +74.3% | 0.00% | – |
| Q3 2020 | $55,000 | -42.1% | 1,174 | -27.3% | 0.00% | – |
| Q2 2020 | $95,000 | -23.4% | 1,615 | -38.8% | 0.00% | – |
| Q1 2020 | $124,000 | -83.7% | 2,639 | -79.0% | 0.00% | -100.0% |
| Q4 2019 | $759,000 | -58.6% | 12,570 | -74.9% | 0.00% | -75.0% |
| Q3 2016 | $1,832,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |